An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity

Free Radical Biology and Medicine

Volumn 22, Issue 4, 1997, Pages 597-605

  Nosaka, Kazuo ^a   Takahashi, Takeshi ^a   Nishi, Tadahiro ^a   Imaki, Hiromi ^a   Suzuki, Takako ^a   Suzuki, Keiji ^a   Kurokawa, Kiyoshi ^a   Endou, Hitoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2' Deoxycoformycin; Adenosine deaminase; Adenosine triphosphate; Cyclic AMP; Free radicals; Glomerular epithelial cells; Puromycin aminonucleoside; Reactive oxygen metabolites

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; PENTOSTATIN; PUROMYCIN AMINONUCLEOSIDE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GLOMERULUS FILTRATION; INHIBITION KINETICS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEPHROSIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SPECIES DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CYCLIC AMP; DOGS; ENZYME INHIBITORS; FREE RADICALS; GUINEA PIGS; HAPLORHINI; KIDNEY; KIDNEY GLOMERULUS; MALE; MICE; MICROSCOPY, ELECTRON; PENTOSTATIN; PUROMYCIN AMINONUCLEOSIDE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SPECIES SPECIFICITY;

ADA; ANIMALIA; CANIS FAMILIARIS; CAVIA PORCELLUS; GLOMERULUS; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0031019311     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00349-8     Document Type: Article

References (32)

1. Hartman M. E., Hartman J. D., Baldridge R. C. Inhibition of aminonucleoside nephrosis by adenine. Proc. Soc. Exp. Biol. Med. 100:1959;152-155.
2. Alexander C. S., Hunt V. R. Inhibition of aminonucleoside nephrosis in rats: II. Effect of nucleic acid precursors and L-triiodothyronine. Proc. Soc. Exp. Biol. Med. 108:1961;706-709.
3. Alexander C. S., Nagasawa H. T., Filbin D. Distribution and excretion of aminonucleoside-8-C14 in normal and nephrotic rats. Proc. Soc. Exp. Biol. Med. 111:1962;521-526.
4. Derr R. F., Alexander C. S., Nagasawa H. T. Metabolism of puromycin aminonucleoside in the normal, "pre-nephrotic," and nephrotic rat. Proc. Soc. Exp. Biol. Med. 125:1967;248-252.
5. 6-methyladenosine. J. Lab. Clin. Med. 72:1968;363-369.
6. Fishman J. A., Karnovsky M. J. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am. J. Pathol. 118:1985;398-407.
7. Ghiggeri G. M., Cercignani G., Ginevri F., Bertelli R., Zetta L., Greco F., Candiano G., Trivelli A., Gusmano R. Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro. Kidney Int. 40:1991;35-42.
8. Diamond J. R., Bonventre J. V., Karnovsky M. J. A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int. 29:1986;478-483.
9. Ginevri F., Gusmano R., Oleggini R., Acerbo S., Bertelli R., Perfumo F., Cercignani G., Allergrini S., D'Allegri F., Ghiggeri G. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: Difference between puromycin aminonucleoside and adriamycin nephrosis. Clin. Sci. Colch. 78:(3):1990;283-293.
10. Beaman M., Birtwistle R., Howie A. J., Michael J., Adu D. The role of superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in rats. Clin. Sci. 73:1987;329-332.
11. Thakur V., Walker P. D., Shah S. V. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int. 34:1988;494-499.
12. Agarwal R. P., Spector T., Parkes R. E. Jr. Tight-binding inhibitors. Inhibition of adenosine deaminase by various inhibitors. Biochem. Pharmacol. 26:1977;359-367.
13. Nosaka K., Nishi T., Imaki H., Suzuki K., Kuwata S., Noiri E., Aizawa C., Kurokawa K. Permeable type I collagen membrane promotes glomerular epithelial cell growth in culture. Kidney Int. 43:1993;470-478.
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
15. Yoshizato K., Nishikawa A., Taira T. Functionally polarized layers formed by epithelial transport and responsiveness to hormones. J. Cell Sci. 91:1988;491-498.
16. Glazer R. I., Lott T. J., Peale A. L. Potentiation by 2′-deoxycoformycin of the inhibitory effect by 3′-deoxyadenosine (cordycepin) on nuclear RNA synthesis in L1210 cells in vitro. Cancer Res. 38:(8):1978;2233-2238.
17. Jung K. Y., Uchida S., Endou H. Nephrotoxicity assessment by measuring ATP content. I. Substrate specificities in the maintenance of ATP content in isolated rat nephron segments. Toxicol. Appl. Pharmacol. 100:1989;369-382.
18. Lemasters J. J., Hackenbrock C. R. Firefly luciferase assay for ATP production by mitochondria. DeLuca M. A. Methods in enzymology. 62:1978;36-50 Academic Press, New York.
19. Uchida S., Endou H. Substrate specificity to maintain cellular ATP along the mouse nephron. Am. J. Physiol. 255:(Renal Fluid Electrolyte Physiol. 24):1988;F977-F983.
20. Takahashi T., Kakuno K., Yamada H., Endou H. Intranephron distribution of purine-metabolizing enzymes in rats. Renal Physiol. Biochem. 12:1989;287-294.
21. Shimada H., Endou H., Sakai F. Distribution of gammaglutamyl transpeptidase and glutaminase isoenzymes in the rabbit single nephron. Jpn. J. Pharmacol. 32:1982;121-129.
22. Miyanoshita A., Takahashi T., Endou H. Inhibitory effect of cyclic AMP on phorbol ester-stimulated production of reactive oxygen metabolites in rat glomeruli. Biochem. Biophys. Res. Commun. 165:1989;519-525.
23. Allen R. C. Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis. DeLuca M. A., McElroy W. D. Methods in enzymology. 133:1986;449-493 Academic Press, New York.
24. Honma M., Satoh T., Takazawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem. Med. 18:1977;257-273.
25. Bohrer M. P., Baylis C., Robertson C. R., Brenner B. M. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J. Clin. Invest. 60:1977;152-161.
26. Michael A. F., Venters H. D., Worthen H. G., Good R. A. Experimental renal disease in monkeys. Lab. Invest. 11:1962;1266-1278.
27. Wilson S. G., Hackel D. B., Horwood S., Nash G., Heymann W. Aminonucleoside nephrosis in rats. Pediatrics. 21:1958;963-973.
28. Abboud H. E., Dousa T. P. Action of adenosine on cyclic 2′,5′-nucleotides in glomeruli. Am. J. Physiol. 244:1983;F633-F638.
29. Shah S. V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 35:1989;1093-1106.
30. 1-type receptor. Kidney Int. 35:1989;1300-1305.
31. Steinhausen M., Endlich K., Wiegman D. L. Renal blood flow. Kidney Int. 38:1990;769-784.
32. Stromski M. E., Waade A. V., Avision M. J., Thulin G., Gaudio K. M., Kashgarian M., Shulman R. G., Siegel N. J. Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats. J. Clin. Invest. 82:1988;1694-1699.